Join EVERSANA at a number of virtual events as we work to advance the commercialization of digital medicines.

“While advancements in digital medicine take us into a new frontier, these devices can and should be available through existing prescription, distribution and reimbursement infrastructures. The commercial model for digital medicine will be efficient, effective and valuable to payers, providers and most importantly, for the patients and caregivers who need them.” Jim Lang, CEO, EVERSANA

For more information on the work we do for Digital Therapeutics or to schedule an appointment with one of our Subject Matter Experts, please contact Jon Kizner by completing our contact us form. 

DTx London: Digital Therapeutics in the COVID-19-Impacted Healthcare Systems
October 21, 2020, 10:00 am BST

In just a few months, huge disruption has occurred to healthcare systems across the world as a result of COVID-19. Digital therapeutics are uniquely positioned to deliver for patients with unmet medical needs where more traditional methods may now not be fit for purpose. Hear from Ed Corbett, Senior Principal, Head of EMEA, on:

  • How has Covid-19 changed our belief in what digital therapeutics can do for patients?
  • What opportunities have opened up due to the recent changes in healthcare systems?
  • How have payers adapted their thoughts on digital therapeutics in this new age?
  • How can we better work with patients to ensure their new behaviours are factored into our products?
  • What more can we do as an industry to ensure digital therapeutics fill the gaps in healthcare where non-digital methods have previously fallen short?

To schedule a meeting with our Digital Medicine experts, contact us here.

HLTH VRTL 2020: DTx & Managed Care – Do Payors Hold the Key to Industry Viability?
October 16, 2020, 1:00 pm ET

Join Ed Cox, EVP, Strategic Alliances and Global Head of Digital Medicine, for a deep-dive into payor partnerships, a critical area for the sustainability of DTx, as well as the spectrum of contemporary payor partnership strategies and share viewpoints on these how these dynamics may change over time. The panel will also discuss areas of focus and investment in DTx.

To schedule a meeting with our Digital Medicine experts, contact us here.


Learn more about the Commercialization of Digital Medicines and EVERSANA’s capabilities.

[Article] Ask the Expert: Digital in Pharma | The Critical Questions

[Podcast] Podcast: The Future of Digital Therapeutics

[Article] 5 Trends in Digital Medicine to Watch For

[Article] What does the new FDA Guidance for DTx Products Treating Psychiatric Disorders actually mean?

[News] EVERSANA and Noom announce strategic partnership to improve therapy adherence and patient engagement for complex therapies. 

[Webinar] Realizing Value from Digital in the Healthcare Environment